Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Largest negative detractor in FY25, hit by pharma R&D spending cuts. Share price fell...
— Kris Webster, Michael Poulsen, and Jack McManus
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on ICON Public Limited Company
ICON Plc fell sharply after announcing an internal investigation into revenue recognition, which the manager views as a temporary overreaction since the restatement impact is expected to be under 2%. The manager added...
LVS Advisory divested from Icon Plc after deeper research revealed that its aggressive M&A strategy created project disruptions, high employee turnover, and substantial debt. Concluding that Medpace's...
LVS purchased Icon Plc expecting strong CRO sector tailwinds and an attractive valuation, but deeper fundamental research revealed critical flaws. The firm's heavy...
More institutional theses from Canopy Investors
SBAC's share price increased 29% in April. SBAC leases mobile...
Visional is positioned to benefit from Japan's structural shifts toward greater mid-career labor mobility due to shrinking demographic trends and labor shortages. Its flagship platform,...
PTC's deterministic software is essential for physical manufacturing and engineering design, making it highly insulated from AI-driven disruption. The company's deep...